header
Image from OpenLibrary

Treatment outcomes of diffuse large B-cell non-Hodgkin{u2019}s lymphoma presenting to Tanta cancer center / Ayman Elsayed Elfakharany ; Supervised Ahmed Abdelmabood Zeeneldin , Ayman Abdelsamie Gaber , Amgad Ahmad Shaheen

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ayman Elsayed Elfakharany , 2014Description: 155 P. : charts ; 25cmOther title:
  • نتائج علاج أورام الغدد الليمفاوية اللاهودجكنية المتسعة كبيرة الخلية من النوع باء في مركز أورام طنطا [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Medical Oncology Summary: Introduction: DLBC-NHL is the most common lymphoid neoplasm and constitutes almost 50% of all NHLs. Methods: This thesis includes 485 patients was conducted to study the outcomes in patients with DLBC-NHL among patients treated at Tanta Cancer Center (TCC) between 2003 and 2006 and followed up till March 2014. Results: 88% of patients received CTx being CHOP in 72.4% of cases. CR was achieved in 62.1%, PFS was 21.4 months. The median OS was 20 months. Conclusions: Outcomes of DBLC-NHL at TCC is comparable to those in the literature. Adding Rituximab is recommended to further improve the treatment
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.M.Sc.2014.Ay.T (Browse shelf(Opens below)) Not for loan 01010110065140000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.M.Sc.2014.Ay.T (Browse shelf(Opens below)) 65140.CD Not for loan 01020110065140000

Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Medical Oncology

Introduction: DLBC-NHL is the most common lymphoid neoplasm and constitutes almost 50% of all NHLs. Methods: This thesis includes 485 patients was conducted to study the outcomes in patients with DLBC-NHL among patients treated at Tanta Cancer Center (TCC) between 2003 and 2006 and followed up till March 2014. Results: 88% of patients received CTx being CHOP in 72.4% of cases. CR was achieved in 62.1%, PFS was 21.4 months. The median OS was 20 months. Conclusions: Outcomes of DBLC-NHL at TCC is comparable to those in the literature. Adding Rituximab is recommended to further improve the treatment

Issued also as CD

There are no comments on this title.

to post a comment.